Venous or arterial samples for activated clotting time measurements: a systematic review

被引:1
|
作者
Iddawela, Sashini [1 ]
Swamy, Priti [2 ]
Member, Sajid [3 ]
Harky, Amer [4 ,5 ,6 ,7 ,8 ]
机构
[1] Univ Hosp Birmingham, Dept Resp Med, Birmingham, W Midlands, England
[2] Kings Coll London, GKT Sch Med Educ, London, England
[3] Univ Cent Lancashire, Lancashire Sch Med & Dent, Greenbank Bldg, Preston, Lancs, England
[4] Liverpool Heart & Chest Hosp, Dept Cardiothorac Surg, Thomas Dr, Liverpool L14 3PE, Merseyside, England
[5] Univ Liverpool, Fac Hlth & Iife Sci, Dept Integrat Biol, Liverpool, Merseyside, England
[6] Univ Liverpool, Liverpool Ctr Cardiovasc Sci, Liverpool, Merseyside, England
[7] Liverpool Heart & Chest Hosp, Liverpool, Merseyside, England
[8] Alder Hey Children Hosp, Dept Cardiac Surg, Liverpool, Merseyside, England
来源
PERFUSION-UK | 2021年 / 36卷 / 08期
关键词
clotting factors; ACT; venous; arterial; cardiac surgery; cardiac catheterisation; COAGULATION TIME; HEPARIN; THROMBOELASTOGRAPHY; SURGERY;
D O I
10.1177/0267659120967836
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The systematic review aims to investigate the effect of sampling source on activated clotting time (ACT) measurement within cardiovascular surgery and cardiac catheterisation. It also examines the evidence surrounding novel clot assessment techniques and associated sampling variation. Methods: A comprehensive electronic search was conducted using PubMed, MEDLINE, Scopus, Cochrane database, and Google Scholar until 20th June 2020. All studies reporting sampling source variability of ACT in cardiac surgery, vascular surgery and cardiac catheterisation were included. Results: Fourteen studies were included in the systematic review. Inconsistent reports of variability were seen in cardiac surgery and cardiac catheterisation. There were no studies directly examining ACT variability in vascular surgery. Novel clot assessment techniques have been validated in cardiac surgery, but measurements vary depending on sampling source. Conclusion: Sampling source should be kept consistent to facilitate effective haemostatic strategies. More research is needed regarding variability in vascular surgery and novel clot assessment techniques.
引用
收藏
页码:845 / 852
页数:8
相关论文
共 50 条
  • [31] Clinical monitoring of activated clotting time during cardiothoracic surgery: comparing the Hemochron(R) Response and Hemochron(R) Signature Elite
    Hoffmann, Roland F.
    Horsten, Sandra
    Mariani, Massimo A.
    de Vries, Adrianus J.
    PERFUSION-UK, 2023, 38 (02): : 285 - 291
  • [32] Effect of heparin, platelets, activated platelets, platelet fragments, and hematocrit on activated clotting time
    Girardi, L
    Sudi, K
    Muntean, W
    ARTIFICIAL ORGANS, 2000, 24 (07) : 507 - 513
  • [33] Optimal activated clotting time during peripheral artery endovascular procedures: cutting the gordian knot
    Patrone, Lorenzo
    Pasqui, Edoardo
    Sheahan, Kevin
    de Donato, Gianmarco
    Thulasidasan, Narayanan
    JOURNAL OF CARDIOVASCULAR SURGERY, 2023, 64 (03): : 240 - 246
  • [34] Assessment of Heparin Anticoagulation Measured Using i-STAT and Hemochron Activated Clotting Time
    Maslow, Andrew
    Chambers, Alison
    Cheves, Tracey
    Sweeney, Joseph
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2018, 32 (04) : 1603 - 1608
  • [35] Physiologically-Based Pharmacokinetic and Pharmacodynamic Modeling of Unfractionated Heparin to Predict Activated Clotting Time
    Regorda, Filippo
    Vigoni, Emiliano
    Pesenti, Giuseppe
    Pieri, Marina
    Belletti, Alessandro
    Manca, Davide
    30TH EUROPEAN SYMPOSIUM ON COMPUTER AIDED PROCESS ENGINEERING, PTS A-C, 2020, 48 : 703 - 708
  • [36] Activated Clotting Time and Radial Artery Occlusion Finding the Sweet Spot
    Gulati, Rajiv
    Mamas, Mamas A.
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2019, 12 (09)
  • [37] Impact of Activated Clotting Time on Post Cardiopulmonary Bypass Blood Loss
    Haider, Adnan
    Yunus, Aftab
    Ul Banna, Hassan
    Farooq, Abdul Asim
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2015, 9 (04): : 1114 - 1119
  • [38] The activated clotting time in cardiac surgery: should Celite or kaolin be used?
    De Vries, Adrianus J.
    Lansink-Hartgring, Annemieke Oude
    Fernhout, Freek-Jan
    Huet, Rolf C. G.
    van den Heuvel, Edwin R.
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2017, 24 (04) : 549 - 554
  • [39] Satisfactory outcome with low activated clotting time in extracorporeal membrane oxygenation
    Hong, Jeong In
    Hwang, Jinwook
    Shin, Hong Ju
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2021, 22 (04) : 1589 - 1594
  • [40] ACTIVATED CLOTTING-TIME VARIABILITY IN PATIENTS UNDERGOING CORONARY ANGIOPLASTY
    WARNER, MF
    MIAN, MS
    MISSRI, JC
    CLINICAL CARDIOLOGY, 1994, 17 (07) : 372 - 374